The MUC1 and Galectin-3 Oncoproteins Function in a MicroRNA-Dependent Regulatory Loop

Molecular Cell

Volumn 27, Issue 6, 2007, Pages 992-1004

  Ramasamy, Selvi ^a   Duraisamy, Sekhar ^a   Barbashov, Sergei ^a   Kawano, Takeshi ^a   Kharbanda, Surender ^a   Kufe, Donald ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

CELLCYLCE; RNA

Indexed keywords

ASPARAGINE; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; GALECTIN 3; MESSENGER RNA; MICRORNA; MUCIN 1; ONCOPROTEIN;

ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN GLYCOSYLATION; PROTEIN INDUCTION; PROTEIN MODIFICATION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; TRANSCRIPTION REGULATION; UPREGULATION;

AMINO ACID SEQUENCE; ANIMALS; ASPARAGINE; CA-15-3 ANTIGEN; CELL LINE, TUMOR; CHO CELLS; CRICETINAE; CRICETULUS; DOWN-REGULATION; GALECTIN 3; GLYCOSYLATION; HUMANS; MICRORNAS; MOLECULAR SEQUENCE DATA; ONCOGENE PROTEINS; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; PROTEIN SUBUNITS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RNA STABILITY; RNA, MESSENGER; UP-REGULATION;

EID: 34748902247     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molcel.2007.07.031     Document Type: Article

References (53)

1. Ahmad N., Gabius H.J., Andre S., Kaltner H., Sabesan S., Roy R., Liu B., Macaluso F., and Brewer C.F. Galectin-3 precipitates as a pentamer with synthetic multivalent carbohydrates and forms heterogeneous cross-linked complexes. J. Biol. Chem. 279 (2004) 10841-10847
2. Akahani S., Nangia-Makker P., Inohara H., Kim H.R., and Raz A. Galectin-3: a novel antiapoptotic molecule with a functional BH1 (NWGR) domain of Bcl-2 family. Cancer Res. 57 (1997) 5272-5276
3. Bagga S., Bracht J., Hunter S., Massirer K., Holtz J., Eachus R., and Pasquinelli A.E. Regulation by let-7 and lin-4 miRNAs results in target mRNA degradation. Cell 122 (2005) 553-563
4. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116 (2004) 281-297
5. Califice S., Castronovo V., and Van Den Brule F. Galectin-3 and cancer. Int. J. Oncol. 25 (2004) 983-992
6. Demetriou M., Granovsky M., Quaggin S., and Dennis J.W. Negative regulation of T-cell activation and autoimmunity by Mgat5 N-glycosylation. Nature 409 (2001) 733-739
7. Dumic J., Dabelic S., and Flogel M. Galectin-3: an open-ended story. Biochim. Biophys. Acta 1760 (2006) 616-635
8. Esquela-Kerscher A., and Slack F.J. Oncomirs - microRNAs with a role in cancer. Nat. Rev. Cancer 6 (2006) 259-269
9. Huang L., Chen D., Liu D., Yin L., Kharbanda S., and Kufe D. MUC1 oncoprotein blocks GSK3β-mediated phosphorylation and degradation of β-catenin. Cancer Res. 65 (2005) 10413-10422
10. Johnson S.M., Grosshans H., Shingara J., Byrom M., Jarvis R., Cheng A., Labourier E., Reinert K.L., Brown D., and Slack F.J. RAS is regulated by the let-7 microRNA family. Cell 120 (2005) 635-647
11. Johnston Jr. R.J., Chang S., Etchberger J.F., Ortiz C.O., and Hobert O. MicroRNAs acting in a double-negative feedback loop to control a neuronal cell fate decision. Proc. Natl. Acad. Sci. USA 102 (2005) 12449-12454
12. Kadrofske M.M., Openo K.P., and Wang J.L. The human LGALS3 (galectin-3) gene: determination of the gene structure and functional characterization of the promoter. Arch. Biochem. Biophys. 349 (1998) 7-20
13. Kasashima K., Nakamura Y., and Kozu T. Altered expression profiles of microRNAs during TPA-induced differentiation of HL-60 cells. Biochem. Biophys. Res. Commun. 322 (2004) 403-410
14. Krutzfeldt J., Rajewsky N., Braich R., Rajeev K.G., Tuschl T., Manoharan M., and Stoffel M. Silencing of microRNAs in vivo with 'antagomirs'. Nature 438 (2005) 685-689
15. Kufe D., Inghirami G., Abe M., Hayes D., Justi-Wheeler H., and Schlom J. Differential reactivity of a novel monoclonal antibody (DF3) with human malignant versus benign breast tumors. Hybridoma 3 (1984) 223-232
16. Lee R.C., and Ambros V. An extensive class of small RNAs in Caenorhabditis elegans. Science 294 (2001) 862-864
17. Levitin F., Stern O., Weiss M., Gil-Henn C., Ziv R., Prokocimer Z., Smorodinsky N.I., Rubinstein D.B., and Wreschner D.H. The MUC1 SEA module is a self-cleaving domain. J. Biol. Chem. 280 (2005) 33374-33386
18. Li Y., Bharti A., Chen D., Gong J., and Kufe D. Interaction of glycogen synthase kinase 3β with the DF3/MUC1 carcinoma-associated antigen and β-catenin. Mol. Cell. Biol. 18 (1998) 7216-7224
19. Li Y., Kuwahara H., Ren J., Wen G., and Kufe D. The c-Src tyrosine kinase regulates signaling of the human DF3/MUC1 carcinoma-associated antigen with GSK3β and β-catenin. J. Biol. Chem. 276 (2001) 6061-6064
20. Li Y., Ren J., Yu W.-H., Li G., Kuwahara H., Yin L., Carraway K.L., and Kufe D. The EGF receptor regulates interaction of the human DF3/MUC1 carcinoma antigen with c-Src and β-catenin. J. Biol. Chem. 276 (2001) 35239-35242
21. Li Y., Chen W., Ren J., Yu W., Li Q., Yoshida K., and Kufe D. DF3/MUC1 signaling in multiple myeloma cells is regulated by interleukin-7. Cancer Biol. Ther. 2 (2003) 187-193
22. Li Y., Liu D., Chen D., Kharbanda S., and Kufe D. Human DF3/MUC1 carcinoma-associated protein functions as an oncogene. Oncogene 22 (2003) 6107-6110
23. Li Y., Yu W.-H., Ren J., Huang L., Kharbanda S., Loda M., and Kufe D. Heregulin targets γ-catenin to the nucleolus by a mechanism dependent on the DF3/MUC1 protein. Mol. Cancer Res. 1 (2003) 765-775
24. Lim L.P., Lau N.C., Garrett-Engele P., Grimson A., Schelter J.M., Castle J., Bartel D.P., Linsley P.S., and Johnson J.M. Microarray analysis shows that some microRNAs downregulate large numbers of target mRNAs. Nature 433 (2005) 769-773
25. Lin H.M., Pestell R.G., Raz A., and Kim H.R. Galectin-3 enhances cyclin D(1) promoter activity through SP1 and a cAMP-responsive element in human breast epithelial cells. Oncogene 21 (2002) 8001-8010
26. Liu F.T., and Rabinovich G.A. Galectins as modulators of tumour progression. Nat. Rev. Cancer 5 (2005) 29-41
27. Macao B., Johansson D.G., Hansson G.C., and Hard T. Autoproteolysis coupled to protein folding in the SEA domain of the membrane-bound MUC1 mucin. Nat. Struct. Mol. Biol. 13 (2006) 71-76
28. Matarrese P., Tinari N., Semeraro M.L., Natoli C., Iacobelli S., and Malorni W. Galectin-3 overexpression protects from cell damage and death by influencing mitochondrial homeostasis. FEBS Lett. 473 (2000) 311-315
29. Nangia-Makker P., Thompson E., Ochieng J., and Raz A. Induction of tumorigenicity by gelectin-3 in a non-tumorigenic human breast carcinoma cell line. Int. J. Oncol. 7 (1995) 1079-1087
30. Ochieng J., Furtak V., and Lukyanov P. Extracellular functions of galectin-3. Glycoconj. J. 19 (2004) 527-535
31. Partridge E.A., Le Roy C., Di Guglielmo G.M., Pawling J., Cheung P., Granovsky M., Nabi I.R., Wrana J.L., and Dennis J.W. Regulation of cytokine receptors by Golgi N-glycan processing and endocytosis. Science 306 (2004) 120-124
32. Patterson R.J., Wang W., and Wang J.L. Understanding the biochemical activities of galectin-1 and galectin-3 in the nucleus. Glycoconj. J. 19 (2004) 499-506
33. Raina D., Kharbanda S., and Kufe D. The MUC1 oncoprotein activates the anti-apoptotic PI3K/Akt and Bcl-xL pathways in rat 3Y1 fibroblasts. J. Biol. Chem. 279 (2004) 20607-20612
34. Raina D., Ahmad R., Kumar S., Ren J., Yoshida K., Kharbanda S., and Kufe D. MUC1 oncoprotein blocks nuclear targeting of c-Abl in the apoptotic response to DNA damage. EMBO J. 25 (2006) 3774-3783
35. Ren J., Li Y., and Kufe D. Protein kinase C δ regulates function of the DF3/MUC1 carcinoma antigen in β-catenin signaling. J. Biol. Chem. 277 (2002) 17616-17622
36. Ren J., Agata N., Chen D., Li Y., Yu W.-H., Huang L., Raina D., Chen W., Kharbanda S., and Kufe D. Human MUC1 carcinoma-associated protein confers resistance to genotoxic anti-cancer agents. Cancer Cell 5 (2004) 163-175
37. Ren J., Bharti A., Raina D., Chen W., Ahmad R., and Kufe D. MUC1 oncoprotein is targeted to mitochondria by heregulin-induced activation of c-Src and the molecular chaperone HSP90. Oncogene 25 (2006) 20-31
38. Schroeder J., Thompson M., Gardner M., and Gendler S. Transgenic MUC1 interacts with epidermal growth factor receptor and correlates with mitogen-activated protein kinase activation in the mouse mammary gland. J. Biol. Chem. 276 (2001) 13057-13064
39. Seetharaman J., Kanigsberg A., Slaaby R., Leffler H., Barondes S.H., and Rini J.M. X-ray crystal structure of the human galectin-3 carbohydrate recognition domain at 2.1-A resolution. J. Biol. Chem. 273 (1998) 13047-13052
40. Shimura T., Takenaka Y., Tsutsumi S., Hogan V., Kikuchi A., and Raz A. Galectin-3, a novel binding partner of beta-catenin. Cancer Res. 64 (2004) 6363-6367
41. Sylvestre Y., De Guire V., Querido E., Mukhopadhyay U.K., Bourdeau V., Major F., Ferbeyre G., and Chartrand P. An E2F/miR-20a autoregulatory feedback loop. J. Biol. Chem. 282 (2007) 2135-2143
42. Takenaka Y., Inohara H., Yoshii T., Oshima K., Nakahara S., Akahani S., Honjo Y., Yamamoto Y., Raz A., and Kubo T. Malignant transformation of thyroid follicular cells by galectin-3. Cancer Lett. 195 (2003) 111-119
43. Takenaka Y., Fukumori T., and Raz A. Galectin-3 and metastasis. Glycoconj. J. 19 (2004) 543-549
44. Takenaka Y., Fukumori T., Yoshii T., Oka N., Inohara H., Kim H.R., Bresalier R.S., and Raz A. Nuclear export of phosphorylated galectin-3 regulates its antiapoptotic activity in response to chemotherapeutic drugs. Mol. Cell. Biol. 24 (2004) 4395-4406
45. van den Brule F., Califice S., and Castronovo V. Expression of galectins in cancer: a critical review. Glycoconj. J. 19 (2004) 537-542
46. Walzel H., Blach M., Hirabayashi J., Arata Y., Kasai K., and Brock J. Galectin-induced activation of the transcription factors NFAT and AP-1 in human Jurkat T-lymphocytes. Cell. Signal. 14 (2002) 861-868
47. Wei X., Xu H., and Kufe D. Human MUC1 oncoprotein regulates p53-responsive gene transcription in the genotoxic stress response. Cancer Cell 7 (2005) 167-178
48. Wei X., Xu H., and Kufe D. MUC1 oncoprotein stabilizes and activates estrogen receptor alpha. Mol. Cell 21 (2006) 295-305
49. Wu L., and Belasco J.G. Micro-RNA regulation of the mammalian lin-28 gene during neuronal differentiation of embryonal carcinoma cells. Mol. Cell. Biol. 25 (2005) 9198-9208
50. Wu L., Fan J., and Belasco J.G. MicroRNAs direct rapid deadenylation of mRNA. Proc. Natl. Acad. Sci. USA 103 (2006) 4034-4039
51. Yin L., and Kufe D. Human MUC1 carcinoma antigen regulates intracellular oxidant levels and the apoptotic response to oxidative stress. J. Biol. Chem. 278 (2003) 35458-35464
52. Yoshii T., Fukumori T., Honjo Y., Inohara H., Kim H.R., and Raz A. Galectin-3 phosphorylation is required for its anti-apoptotic function and cell cycle arrest. J. Biol. Chem. 277 (2002) 6852-6857
53. Yu F., Finley Jr. R.L., Raz A., and Kim H.R. Galectin-3 translocates to the perinuclear membranes and inhibits cytochrome c release from the mitochondria. A role for synexin in galectin-3 translocation. J. Biol. Chem. 277 (2002) 15819-15827